Observational RealWorld Evidence Observational studies generally suggested that tirzepatide may produce clinically meaningful body weight reduction in adults with T1D, especially in populations enriched for overweight or obesity [10, 11, 12, 13, 14, 15, 16]
Weight Loss May Reduce CPAP Dependence Some patients with weight-related OSA may no longer need CPAP after significant weight loss, but experts stress that patients should continue CPAP until a doctor confirms improvement through follow-up testing
In any case, put the medication back in the fridge when you find it
genital yeast infections and dehydration risks are more typical with empagliflozin
However, it's essential to approach this treatment with realistic expectations and a solid understanding of what it can and cannot do